全文获取类型
收费全文 | 814篇 |
免费 | 97篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 24篇 |
妇产科学 | 36篇 |
基础医学 | 134篇 |
口腔科学 | 16篇 |
临床医学 | 83篇 |
内科学 | 191篇 |
皮肤病学 | 28篇 |
神经病学 | 25篇 |
特种医学 | 83篇 |
外科学 | 91篇 |
综合类 | 13篇 |
预防医学 | 28篇 |
眼科学 | 13篇 |
药学 | 46篇 |
2篇 | |
中国医学 | 4篇 |
肿瘤学 | 107篇 |
出版年
2022年 | 3篇 |
2021年 | 7篇 |
2020年 | 15篇 |
2019年 | 35篇 |
2018年 | 36篇 |
2017年 | 29篇 |
2016年 | 21篇 |
2015年 | 31篇 |
2014年 | 33篇 |
2013年 | 36篇 |
2012年 | 33篇 |
2011年 | 34篇 |
2010年 | 41篇 |
2009年 | 26篇 |
2008年 | 22篇 |
2007年 | 51篇 |
2006年 | 33篇 |
2005年 | 29篇 |
2004年 | 35篇 |
2003年 | 25篇 |
2002年 | 20篇 |
2001年 | 28篇 |
2000年 | 17篇 |
1999年 | 13篇 |
1998年 | 20篇 |
1997年 | 19篇 |
1996年 | 18篇 |
1995年 | 13篇 |
1994年 | 17篇 |
1993年 | 12篇 |
1992年 | 10篇 |
1991年 | 10篇 |
1990年 | 6篇 |
1989年 | 14篇 |
1988年 | 15篇 |
1987年 | 14篇 |
1986年 | 12篇 |
1985年 | 8篇 |
1984年 | 10篇 |
1983年 | 11篇 |
1982年 | 9篇 |
1981年 | 10篇 |
1980年 | 8篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1976年 | 5篇 |
1975年 | 7篇 |
1969年 | 3篇 |
1968年 | 2篇 |
1966年 | 2篇 |
排序方式: 共有928条查询结果,搜索用时 31 毫秒
31.
32.
Ryan S. Hsi James M. Hotaling Tarah N. Moore Byron D. Joyner 《World journal of urology》2013,31(3):697-702
Purpose
To assess the extent and types of publication misrepresentation among medical students applying to the urology residency program at the University of Washington. Research experience and publications are the selection criteria used to judge and rank urology residency applicants.Methods
Electronic Residency Application Service (ERAS) applications submitted for the incoming class of 2011 for urology residency at the University of Washington were reviewed. All listed publications were verified against PubMed and Google search engines. Misrepresentation was defined as non-authorship of an existing article, authorship claimed of a nonexistent article, or first-authorship listed incorrectly.Results
Of the 198 total applications, 124 (63 %) applicants reported 541 publications, including 112 abstracts and 429 journal articles. 347 (65 %) articles and abstracts were verifiable. Misrepresentation of 12 (3.5 %) published articles was found in 9 applicants (7 %), which included self-promotion to first-authorship (6), followed by non-existent articles (5), and a repeated publication listing (1). On univariate analysis, higher age (p = 0.008), higher number of total publications reported (p < 0.001), additional graduate degree (p < 0.001), and foreign medical graduate (FMG) status (p < 0.001) were associated with misrepresentation. Due to the low incidence, the study was not adequately powered to perform a multivariate analysis.Conclusions
Misrepresentation of publications listed in ERAS among urology applicants remains significant. Residency program directors should require applicants to submit copies of all of their publications, whether in print, in-press, or submitted to be placed as part of their application file. 相似文献33.
Nichiporov D Solberg K Hsi W Wolanski M Mascia A Farr J Schreuder A 《Medical physics》2007,34(7):2683-2690
Two beam profile measurement detectors have been developed at Indiana University Cyclotron Facility to address the need for a tool to efficiently verify dose distributions created with active methods of clinical proton beam delivery. The multipad ionization chamber (MPIC) has 128 ionization chambers arranged in one plane and is designed to measure lateral profiles in fields up to 38 cm in diameter. The MPIC pads have a 5 mm pitch for fields up to 20 cm in diameter and a 7 mm pitch for larger fields, providing the accuracy of field size determination about 0.5 mm. The multilayer ionization chamber (MLIC) detector contains 122 small-volume ionization chambers stacked at a 1.82 mm step (water-equivalent) for depth-dose profile measurements. The MLIC detector can measure profiles up to 20 cm in depth, and determine the 80% distal dose fall-off with about 0.1 mm precision. Both detectors can be connected to the same set of electronics modules, which comprise the detectors' data acquisition system. The detectors have been tested in clinical proton fields produced with active methods of beam delivery such as uniform scanning and energy stacking. This article describes detector performance tests and discusses their results. The test results indicate that the MPIC and MLIC detectors can be used for dosimetric characterization of clinical proton fields. The detectors offer significant time savings during measurements in actively delivered beams compared with traditional measurements using a water phantom. 相似文献
34.
35.
Arruda VR; Pieneman WC; Reitsma PH; Deutz-Terlouw PP; Annichino-Bizzacchi JM; Briet E; Costa FF 《Blood》1995,86(8):3015-3020
The molecular characterization of the mutations in hemophilia A patients is hampered by the large size of the factor VIII gene and the great heterogeneity of mutations. In this study, we have performed a protocol involving multiplex polymerase chain reaction in which 19 exons were amplified in four different combinations followed by nonradioactive single-strand conformational polymorphism (SSCP) to screen for mutations. Southern blotting was used to detect inversion of the factor VIII gene resulting from recombination between copies of the gene A (F8A) located in intron 22 of the factor VIII gene and two copies close telomeric region of X chromosome. Forty-two hemophilia A patients (21 with severe and 21 with mild-to-moderate disease) were studied. The inversion of factor VIII occurred in 13 of 21 patients affected by severe hemophilia A. One patient showed a large extra band in addition to the three bands observed after Southern blotting with the F8A probe. An abnormal electrophoretic pattern of SSCP was detected in 85% and 50% of the patients affected by mild-to-moderate and severe disease, respectively. Sixteen different mutations were identified. Eleven mutations were novel and comprised 9 point mutations and 2 small deletions. This study shows that the methodology used is safe and rapid and has potential for detecting almost all of the genetic defects of the studied hemophilia A patients. 相似文献
36.
Rex C.‐C. Huang MS Anssi Auvinen PhD Matti Hakama PhD Teuvo L. J. Tammela PhD Martti Ala‐Opas PhD Mikael Leppilahti PhD Timo Vornanen MD Hsiu‐Hsi Chen PhD 《Health expectations》2014,17(6):776-783
Background
Patient preference for the choice of treatment modality for prostate cancer has increasingly gained attention.Objective
To assess the impact of client‐oriented decision on long‐term mortality, disease progression and biochemical failure compared with standard treatment protocol (TP).Methods
With data from a Finnish multicentre, randomized controlled trial with two arms [104 in the enhanced patient participation (EPP) arm and 106 in the TP arm], disease‐specific and disease‐free survival, biochemical failure with elevated prostate‐specific antigen (PSA) level and disease progression were compared between the two arms using Wilcoxon test and also Cox proportional hazards regression model.Results
Patients in the EPP arm had a higher risk of death by 37% [HR, 1.37 (0.87–2.17)] compared with those in the TP arm. Patients in the EPP arm were at increased risk of having biochemical failure by 14% [HR, 1.14 (0.72–1.79)] and for having disease progression by 2% [HR, 1.02 (0.61–1.70)] compared with those in the TP arm. All the differences were non‐significant.Conclusions
Patients actively involved in the choice of treatment had higher risk of prostate cancer death but only slightly increased risk of biochemical failure and clinical disease progression. These findings would provide a good reference when patient autonomy for the choice of treatment modality is addressed. 相似文献37.
38.
Yen‐Tze Liu Ming‐Ju Hsieh Jen‐Tsun Lin Gene Chen Chia‐Chieh Lin Yu‐Sheng Lo Yi‐Ching Chuang Yi‐Ting Hsi Mu‐Kuan Chen Ming‐Chih Chou 《Environmental toxicology》2019,34(4):513-520
The incidence of oral cancer is increasing all over the world, with rates particularly high in Southeast Asian countries, such as Taiwan. Coronarin D (CD) has been confirmed to have anti‐inflammatory, anti‐bacterial effects, and anti‐apoptotic effects in human hepatocellular carcinoma and nasopharyngeal carcinoma. The purpose of this study is to explore whether CD has a suppression effect on oral cancer cells and the mechanisms involved. The results of our study revealed the significantly decreased cancer cell viability and increased activation of apoptosis via increased loss of mitochondrial membrane potential, increased death receptors, leading to the activation of caspase‐8, ‐9, ‐3. Moreover, the rate of apoptosis of cells treated with CD plus JNK inhibitors was decreased compared to CD‐treated cells. This is the first study to demonstrate that CD induces apoptosis in human oral cancer cells and can be expected to be a promising anticancer agent for oral cancer treatment. 相似文献
39.